Alpha variant SARS-CoV-2 infection: How it all starts

Pere Domingo; Natividad de Benito

doi:10.1016/j.ebiom.2021.103703

Alpha variant SARS-CoV-2 infection: How it all starts

Pere Domingo^*, Natividad de Benito

^*Autor corresponent d’aquest treball

Departament de Medicina

Producció científica: Contribució a revista › Article › Recerca › Avaluat per experts

19 Cites (Scopus)

Idioma original	Anglès
Número d’article	103703
Revista	EBioMedicine
Volum	74
DOIs	https://doi.org/10.1016/j.ebiom.2021.103703
Estat de la publicació	Publicada - de des. 2021

Accés al document

10.1016/j.ebiom.2021.103703

Altres arxius i enllaços

Link to publication in Scopus

Com citar-ho

@article{eaa00897001347ad8d3b1f8813849771,

title = "Alpha variant SARS-CoV-2 infection: How it all starts",

author = "Pere Domingo and \{de Benito\}, Natividad",

note = "Funding Information: This work was partially supported by the grant COV20/00070 (to PD), Instituto de Salud Carlos III, Madrid, Spain. PD is supported by a grant from the Programa de Intensificaci?n de Investigadores (INT19/00036), Instituto de Salud Carlos III, Madrid, Spain. Funding Information: This work was partially supported by the grant COV20/00070 (to PD), Instituto de Salud Carlos III, Madrid, Spain. PD is supported by a grant from the Programa de Intensificaci{\'o}n de Investigadores (INT19/00036), Instituto de Salud Carlos III, Madrid, Spain.",

year = "2021",

month = dec,

doi = "10.1016/j.ebiom.2021.103703",

language = "English",

volume = "74",

journal = "EBioMedicine",

issn = "2352-3964",

publisher = "Elsevier BV",

}

TY - JOUR

T1 - Alpha variant SARS-CoV-2 infection

T2 - How it all starts

AU - Domingo, Pere

AU - de Benito, Natividad

N1 - Funding Information: This work was partially supported by the grant COV20/00070 (to PD), Instituto de Salud Carlos III, Madrid, Spain. PD is supported by a grant from the Programa de Intensificaci?n de Investigadores (INT19/00036), Instituto de Salud Carlos III, Madrid, Spain. Funding Information: This work was partially supported by the grant COV20/00070 (to PD), Instituto de Salud Carlos III, Madrid, Spain. PD is supported by a grant from the Programa de Intensificación de Investigadores (INT19/00036), Instituto de Salud Carlos III, Madrid, Spain.

PY - 2021/12

Y1 - 2021/12

UR - https://www.scopus.com/pages/publications/85119253231

U2 - 10.1016/j.ebiom.2021.103703

DO - 10.1016/j.ebiom.2021.103703

M3 - Article

C2 - 34800902

AN - SCOPUS:85119253231

SN - 2352-3964

VL - 74

JO - EBioMedicine

JF - EBioMedicine

M1 - 103703

ER -